SF3B1 and B-cell chronic lymphocytic leukemia: Comparison of CLL cells with SF3B1 mutation/del(13q) to CLL cells either with del(13q) or SF3B1 mutations revealed enrichment for mTORC1 pathway and BCR signaling associated with SF3B1 mutation but not del(13q) (Supplemental Figure 4C).